Evidence map›Paper›PMID 36862485›Full record

Trial reportJMIR public health and surveillance2023

A Pay-It-Forward Approach to Improve Chlamydia and Gonorrhea Testing Uptake Among Female Sex Workers in China: Venue-Based Superiority Cluster Randomized Controlled Trial.

Weiming Tang, Yewei Xie, Mingzhou Xiong, Dan Wu, Jason J Ong, Teodora Elvira Wi, Bin Yang, Joseph D Tucker, Cheng Wang

Open access · goldFull text readRandomized Controlled TrialEquivalence Trial
In one paragraph

Trial report in JMIR public health and surveillance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 6 countries.

Weiming TangDermatology Hospital of Southern Medical University, Guangzhou, China.ORCID 0000-0002-9026-707X
Yewei XieUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0002-5054-4917
Mingzhou XiongDermatology Hospital of Southern Medical University, Guangzhou, China.ORCID 0000-0002-7146-1838
Dan WuUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0003-0415-5467
Jason J OngDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0001-5784-7403
Teodora Elvira WiDepartment of Global HIV, Hepatitis and STI Programmes, World Health Organization Headquarters, Geneva, Switzerland.ORCID 0000-0002-7640-9166
Bin YangDermatology Hospital of Southern Medical University, Guangzhou, China.ORCID 0000-0002-7155-6079
Joseph D TuckerUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0003-2804-1181
Cheng Wang *Dermatology Hospital of Southern Medical University, Guangzhou, China.ORCID 0000-0001-8000-9969
University of North Carolina at Chapel Hill · USSouthern Medical University · CNLondon School of Hygiene & Tropical Medicine · GBWorld Health Organization · CH

Funding

Pay-it-forward gonorrhea testing among men who have sex with men: The PIONEER pragmatic randomized controlled trialR01AI158826 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TANG, WEIMING, TUCKER, JOSEPH DAVID · 2021 to 2025
$3.1M
Mentoring Multidisciplinary Global HIV Patient-Oriented ResearchK24AI143471 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph David Tucker · 2019 to 2026
$1.4M
Enhancing Partner Services among Men Who Have Sex with Men Living With HIV: A Pilot Randomized Controlled TrialR34MH119963 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TANG, WEIMING, TUCKER, JOSEPH DAVID · 2019 to 2021
$568k
NIAID NIH HHS K24 AI143471NIAID NIH HHS R01 AI158826NIMH NIH HHS R34 MH119963World Health Organization 001
6 · The paper itself

Abstract

backgroundRegular chlamydia and gonorrhea testing are essential for key populations, such as female sex workers (FSWs). However, testing cost, stigma, and lack of access prevent FSWs in low- and middle-income countries from receiving chlamydia and gonorrhea testing. A social innovation to address these problems is "pay it forward," where an individual receives a gift (free testing) and then asks whether they would like to give a gift to another person in the community.

objectiveThis cluster randomized controlled trial examined the effectiveness and cost of the pay-it-forward strategy in increasing access to chlamydia and gonorrhea testing among FSWs in China.

methodsThis trial integrated a pay-it-forward approach into a community-based HIV outreach service. FSWs (aged 18 years or older) were invited by an outreach team from 4 Chinese cities (clusters) to receive free HIV testing. The 4 clusters were randomized into 2 study arms in a 1:1 ratio: a pay-it-forward arm (offered chlamydia and gonorrhea testing as a gift) and a standard-of-care arm (out-of-pocket cost for testing: US $11). The primary outcome was chlamydia and gonorrhea test uptake, as ascertained by administrative records. We conducted an economic evaluation using a microcosting approach from a health provider perspective, reporting our results in US dollars (at 2021 exchange rates).

resultsOverall, 480 FSWs were recruited from 4 cities (120 per city). Most FSWs were aged ≥30 years (313/480, 65.2%), were married (283/480, 59%), had an annual income <US $9000 (301/480, 62.7%), and had never been tested for chlamydia (401/480, 83.5%) or gonorrhea (397/480, 82.7%). Chlamydia and gonorrhea test uptake in the pay-it-forward and standard-of-care arms were 82% (197/240) and 4% (10/240), respectively, with an adjusted proportion difference of 76.7% (lower bound 95% CI 70.8%). All those who tested positive were referred to and received treatment at local sexually transmitted infection clinics. This finding was consistent when adjusting for marital status, income, inconsistent condom use during commercial sex in the last 3 months, and HIV testing history. Among 197 women who received tests in the pay-it-forward arm, 99 (50.3%) donated money, with a median donation of US $1.54 (IQR 0.77-1.54). The economic cost per person tested was US $568.71 for standard of care and US $43.20 for pay it forward.

conclusionsThe pay-it-forward strategy has the potential to enhance chlamydia and gonorrhea testing for Chinese FSWs and may be useful for scaling up preventive services. Further implementation research is needed to inform the transition of pay-it-forward research into practice.

trial registrationChinese Clinical Trial Registry ChiCTR2000037653; https://www.chictr.org.cn/showprojen.aspx?proj=57233.

Indexed as

ChlamydiaGonorrheaSex WorkersChinaFemaleHumansSex WorkcareChinachlamydiacommunitycostfemale sex workersgonorrheaHIVimplementationpay-it-forwardpreventionresearchSTDstigmatestingwomen

Identifiers

PMID36862485
PMCPMC10020898
OpenAlexW4322758168

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read61
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.